Application of molecular imaging technology in tumor immunotherapy

Area of Science:

• Oncology
• Medical Imaging
• Immunology

Background:

• Cancer immunotherapy demonstrates significant anti-tumor efficacy but faces challenges including toxicity and non-response in some patients.
• The dynamic and heterogeneous nature of tumors, coupled with a lack of ideal companion biomarkers, complicates treatment selection.
• Understanding the complex tumor microenvironment is crucial for effective cancer treatment strategies.

Purpose of the Study:

• To highlight the potential of molecular imaging in addressing challenges in cancer immunotherapy.
• To emphasize the need for novel imaging biomarkers for personalized treatment selection.
• To explore future imaging strategies for patient stratification in immunotherapy.

Main Methods:

• Review of molecular imaging technologies, specifically positron emission tomography (PET) and single-photon emission computed tomography (SPECT).
• Discussion of the role of imaging in detecting tumor behavior and response to immunotherapy.
• Exploration of the identification of novel imaging biomarkers.

Main Results:

• Molecular imaging techniques like PET and SPECT show promise for non-invasive tumor detection and assessment of immunotherapy response.
• Identification of novel imaging biomarkers could enable personalized treatment plans.
• Future imaging strategies may aid in early patient stratification for immunotherapy.

Conclusions:

• Molecular imaging is a promising tool for overcoming challenges in cancer immunotherapy.
• Developing novel imaging biomarkers is essential for personalized medicine and improving patient outcomes.
• Advanced imaging strategies can guide oncologists in selecting and monitoring immunotherapy treatments.